Drugs@FDA: FDA-Approved Drugs

Home | Previous Page

Abbreviated New Drug Application (ANDA): 079246
Company: TEVA PHARMS USA

Products on ANDA 079246

Drug Name	Active Ingredients	Strength	Dosage Form/Route	Marketing Status	TE Code	RLD	RS
ABACAVIR SULFATE AND LAMIVUDINE	ABACAVIR SULFATE; LAMIVUDINE	EQ 600MG BASE;300MG	TABLET;ORAL	Discontinued	None	No	No

Approval Date(s) and History, Letters, Labels, Reviews for ANDA 079246

Original Approvals or Tentative Approvals

Action Date	Submission	Action Type	Submission Classification	Review Priority; Orphan Status	Letters, Reviews, Labels, Patient Package Insert	Notes	Url
09/29/2016	ORIG-1	Approval			Label (PDF) Letter (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2016/079246s000lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2016/079246Orig1s000ltr.pdf

Supplements

Action Date	Submission	Supplement Categories or Approval Type	Letters, Reviews, Labels, Patient Package Insert	Note	Url
06/21/2023	SUPPL-11	Labeling-Package Insert, Labeling-Medication Guide		Label is not available on this site.
11/12/2020	SUPPL-9	Labeling-Package Insert, Labeling-Medication Guide		Label is not available on this site.
11/12/2020	SUPPL-6	Labeling-Package Insert, Labeling-Medication Guide		Label is not available on this site.
11/12/2020	SUPPL-4	Labeling-Medication Guide, Labeling-Package Insert		Label is not available on this site.

Labels for ANDA 079246

Action Date	Submission	Supplement Categories or Approval Type	Letters, Reviews, Labels, Patient Package Insert	Note	Url
09/29/2016	ORIG-1	Approval	Label (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2016/079246s000lbl.pdf